IMMUNOGENIC PROPERTIES OF RECOMBINANT MOZAIC PROTEINS BASED ON ANTIGENS NS4A AND NS4B OF HEPATITIS C VIRUS

IMMUNOGENIC PROPERTIES OF RECOMBINANT MOZAIC PROTEINS BASED ON ANTIGENS NS4A AND NS4B OF HEPATITIS C VIRUS

The aim of the study was to investigate immunogenic properties of mosaic recombinant proteins constructed on the data of hepatitis C virus NS4A and NS4B antigens. Four mosaic recombinant proteins, containing the T and B epitopes of the NS4A and NS4B antigens, were created by genetic engineering meth...

Full description

Bibliographic Details
Main Authors:	V. V. Koupriyanov, L. I. Nikolaeva, A. A. Zykova, P. I. Makhnovskiy, R. Y. Kotlyarov, A. V. Vasilyev, N. V. Ravin
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2018-06-01
Series:	Вопросы вирусологии
Subjects:	hepatitis c virus antigens recombinant mosaic proteins adjuvant components
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/198/108

Similar Items

The Investigation of the Prospects for Using NS4A Antigen of Hepatitis C Virus for the Development of Recombinant Mosaic Vaccines with Self-Adjuvant Properties
by: V. V. Koupriyanov, et al.
Published: (2017-02-01)

Novel Universal Recombinant Rotavirus A Vaccine Candidate: Evaluation of Immunological Properties
by: Dmitriy L. Granovskiy, et al.
Published: (2024-03-01)

New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses
by: Dmitriy L. Granovskiy, et al.
Published: (2022-09-01)

Expression and purification of recombinant coat protein of sugarcane mosaic virus from Indonesian isolate as an antigen for antibody production
by: Natalia Tri Astuti, et al.
Published: (2019-06-01)

COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
by: N. I. Mikshis, et al.
Published: (2018-11-01)

Designing Stable <i>Bacillus anthracis</i> Antigens with a View to Recombinant Anthrax Vaccine Development
by: Ekaterina M. Ryabchevskaya, et al.
Published: (2022-04-01)

Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1
by: Rothan Hussin A, et al.
Published: (2012-11-01)

EFFECTS OF DIFFERENT ADJUVANTS UPON IMMUNOGENICITY OF ANTI-GROUP B STREPTOCOCCAL VACCINE COMPONENTS
by: A. N. Suvorov, et al.
Published: (2014-07-01)

Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate
by: F Javadi, et al.
Published: (2016-05-01)

Genetic stability of the HA, NA, and NS genes of the recombinant vector virus FluNS1-124-Omp16 (H5N1) expressing the brucellar gene
by: S. O. Sadikaliyeva, et al.
Published: (2015-08-01)

Utility of NS1 Antigen for Diagnosis of Dengue Virus Infection
by: Pramod S. Manthalkar, et al.
Published: (2017-01-01)

Loss of heterozygosity and carrier identification in Duchenne muscular dystrophy: a familiar case with recombination event
by: Fonseca-Mendoza Dora Janeth, et al.
Published: (2012-04-01)

Evolution of <it>African cassava mosaic virus </it>by recombination between bipartite and monopartite begomoviruses
by: Tiendrébéogo Fidèle, et al.
Published: (2012-03-01)

Evaluation of humoral immune responses of experimental animals to the recombinant SARS-CoV-2 spike ectodomain with the ISCOM adjuvant
by: V. A. Evseenko, et al.
Published: (2023-12-01)

Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide
by: Anna A. Zykova, et al.
Published: (2020-10-01)

The analysis of immunoreactivity of individual B-cell epitopes of hepatitis C virus <i>(Flaviviridae: Hepacivirus: Hepatitis С virus)</i> NS4a antigen
by: Lyudmila I. Nikolaeva, et al.
Published: (2022-09-01)

Production of Recombinant Echinococcus granulosus Antigen B Subunits, In Order to Using Of Them in Serodiagnostic Tests of Hydatidosis
by: R Pazoki, et al.
Published: (2007-03-01)

Two approaches for the stabilization of Bacillus anthracis recombinant protective antigen
by: Ekaterina M. Ryabchevskaya, et al.
Published: (2021-02-01)

Detection of recombinant dengue virus 2 NS1 protein in Aedes aegypti mosquitoes using commercial Dengue NS1 ELISA kit
by: Philip Raj Abraham, et al.
Published: (2022-01-01)

STUDIES ON PROTECTIVE EFFECTS OF A VACCINE, BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS
by: V. V. Yeremeev, et al.
Published: (2017-05-01)

Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine
by: I. V. Krasilnikov, et al.
Published: (2022-07-01)

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles
by: Gabriela Brzuska, et al.
Published: (2023-02-01)

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection
by: Lappalainen Maija, et al.
Published: (2009-06-01)

Dengue NS1 Antigen - for Early Detection of Dengue Virus Infection
by: Amol Hartalkar, et al.
Published: (2015-08-01)

A new method of producing NS5A antigen of hepatitis C virus
by: T. V. Kuznetsova, et al.
Published: (2017-02-01)

Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis
by: Isaac Queiroz de Oliveira, et al.
Published: (2015-01-01)

The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets
by: Hangjie Zhang, et al.
Published: (2022-10-01)

Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant <i>N</i>-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
by: Ekaterina I. Lesnova, et al.
Published: (2021-06-01)

Latex agglutination test for rapid on-site serodiagnosis of Japanese encephalitis in pigs using recombinant NS1 antigen
by: M R Grace, et al.
Published: (2019-01-01)

IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus
by: Vanessa Costa dos Santos, et al.
Published: (2019-03-01)

A 4d non-BPS NS-NS microstate
by: Soumangsu Chakraborty, et al.
Published: (2023-09-01)

PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
by: I. V. Dukhovlinov, et al.
Published: (2015-04-01)

SAFETY AND IMMUNOGENICITY OF COLD-ADAPTED RECOMBINANT INFLUENZA VECTOR EXPRESSING ESAT-6 AND AG85А ANTIGENS OF M. TUBERCULOSIS
by: M. V. Sergeeva, et al.
Published: (2017-12-01)

Studying the Immunogenic Properties of Plague Microbe Capsule Antigen F1 Conjugated with Nanoparticles of Colloid Gold and Silver
by: M. N. Kireev, et al.
Published: (2008-04-01)

Engineering E. coli recombinant strains for high yield production of Burkholderia pseudomallei specific antigens
by: Yu. A. Kuzyutina, et al.
Published: (2019-05-01)

In vitro effects of 5 recombinant antigens of Eimeria maxima on maturation, differentiation, and immunogenic functions of dendritic cells derived from chicken spleen
by: Muhammad Haseeb, et al.
Published: (2020-11-01)

Effect of thioredoxin on the immunogenicity of the recombinant P32 protein of lumpy skin disease virus
by: Kanat Tursunov, et al.
Published: (2022-10-01)

Evaluating Recombinant Antigen ROP1 Efficacy in Diagnosis of Toxoplasma Gondii Infection
by: F Keshavarzi
Published: (2015-07-01)

Enhancement of the immunogenicity of influenza A virus by the inhibition of immunosuppressive function of NS1 protein
by: Kirill A. Vasilyev, et al.
Published: (2018-10-01)

Isolation, Cloning, Expression and Purification of Recombinant RhD Antigen from Cord Blood
by: M Habibi Roudkenar, et al.
Published: (2008-09-01)